Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) EBITDA (2020 - 2025)

Alignment Healthcare (ALHC) has disclosed EBITDA for 6 consecutive years, with -$10.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 98.45% year-over-year to -$10.3 million, compared with a TTM value of $36.8 million through Dec 2025, up 105.05%, and an annual FY2025 reading of $14.8 million, up 100.59% over the prior year.
  • EBITDA was -$10.3 million for Q4 2025 at Alignment Healthcare, down from $15.7 million in the prior quarter.
  • Across five years, EBITDA topped out at $97.6 million in Q4 2021 and bottomed at -$662.3 million in Q4 2024.
  • Average EBITDA over 5 years is -$46.7 million, with a median of -$25.9 million recorded in 2023.
  • Peak annual rise in EBITDA hit 519.63% in 2021, while the deepest fall reached 3106.09% in 2021.
  • Year by year, EBITDA stood at $97.6 million in 2021, then tumbled by 148.59% to -$47.5 million in 2022, then increased by 23.97% to -$36.1 million in 2023, then plummeted by 1735.54% to -$662.3 million in 2024, then skyrocketed by 98.45% to -$10.3 million in 2025.
  • Business Quant data shows EBITDA for ALHC at -$10.3 million in Q4 2025, $15.7 million in Q3 2025, and $29.8 million in Q2 2025.